The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Roche's MS med ocrelizumab hits FDA fast track, eyeing earlier-than-expected launch

New Roche PD-L1 Tecentriq shines in study of untreated bladder cancer patients

Mylan's Herceptin biosim matches Roche original in safety, efficacy study